期刊文献+

针对AK12的小分子干扰RNA抑制胶质瘤细胞的增殖 被引量:1

Inhibitory Effects of Plasmid-Based siRNA Targeting AKT2 on Tumor Proliferation in C6 Glioma Cells
原文传递
导出
摘要 目的比较靶向性丝/苏氨酸激酶2(AKT2)不同的小分子干扰RNA构建体对脑胶质瘤细胞增殖的抑制作用。方法选择大鼠AKT2的3个siRNA靶序列构建靶向AKr2的siRNA表达质粒,进行对C6细胞的AKT2表达及增殖抑制的研究,蛋白印迹检测AKT2的表达水平,TUNEL法分析细胞凋亡,流式细胞术分析细胞周期变化,~3H-TdR掺入法分析细胞增殖。结果转染siRNA表达质粒组AKT2表达下调72%、88%和91%。各转染组的凋亡率明显增加(x^2:34.218,P<0.001),转染后S期指数较对照细胞明显减少,转染组细胞自第2天起存活率均明显下降(P<0.01),且各个转染组之间存活率也有极显著性差异(P<0.01),以尾部调节结构域转染组最显著。结论靶向AKT2的siRNA表达质粒可以特异性地抑制AKT2的表达,显著抑制肿瘤细胞增殖并诱导细胞凋亡。 Objective To study the inhibitory effects of plasmid-based siRNA targeting AKT2 on tumor proliferation in c6 glioma cells. Methods Three siRNA expression constructs, which target the sequences of AKT2' s 3 different domains of rat (144-164, 728-748 and 1241-1261, respectively), were transfected into C6 cells mediated by Lipofectamine. Western blot was used to detect AKT2 expression. Cell apoptosis was detected for apoptotic index (AI) by using TUNEL method. Cell cycle was analyzed by flow cytometry and cell proliferative activities were measured by ~3H-TdR. Results The expression of AKT2 was decreased by 72%, 88% and 91% respectively in siRNA constructs transfected groups, as indicated by Western blot. Virtually no apoptotic cells were found in parental cells or the cells transfected with empty vector as indicated by TUNEL assay. Apoptosis was increased in siRNA constructs transfected cells. The flow cytometric analysis showed that the S phase fraction (SPF) was lowered in three siRNA constructs transfected cells than those in parental cells and the cells transfected with empty vector. Compared to parental cells and the cells transfected with empty vector, the ~3H-TdR assay indicated that the survival rates of transfected cells dramatically dropped from the second day after implantation. The siRNA transfected cells revealed much lower survival rate than parental and empty-transfected cells. Conclusion The siRNA expressing constructs targeting AKT2 could specifically suppress AKT2 expression, induce gene silencing and inhibit cell growth.
出处 《医学分子生物学杂志》 CAS CSCD 2005年第4期266-269,共4页 Journal of Medical Molecular Biology
关键词 AKT2 小分子干扰RNA 胶质瘤 增殖 AKT2 siRNA glioma proliferation
  • 相关文献

参考文献7

  • 1浦佩玉.继续加强和深入进行脑胶质瘤的基础研究[J].中华神经外科杂志,2004,20(5):351-352. 被引量:15
  • 2董伦,浦佩玉.胶质瘤中EGFR基因异常及其靶向性治疗研究进展[J].国外医学(遗传学分册),2004,27(1):46-50. 被引量:4
  • 3Vojtek AB, Taylor J, DeRuiter SL, et al. Akt regulates basic helix-loop-helix transcription factor-coactivator complex formation and activity during neuronal differentiation. Mol Cell Biol, 2003, 23:4 417-27.
  • 4Knobbe CB, Reifenberger G. Genetic alterations and aberrant expression of genes related to the phosphatidyl-inositol-3 '-kinase/protein kinase B (Akt) signal transduction pathway in glioblastomas. Brain Pathol, 2003, 13: 507-18.
  • 5董伦,浦佩玉.RNA干扰技术在肿瘤基因治疗研究中的应用[J].国外医学(肿瘤学分册),2004,31(3):172-176. 被引量:2
  • 6Czaudema F, Fechtner M, Aygtn H. Funcitional studies of the PI (3) -kinase signaling pathway employing synthetic and expressed siRNA. Nucl Acids Res, 2003, 31: 670-82.
  • 7Katome T, Obata T, Matsushima R, et al. Use of RNA interference-mediated gene silencing and adenoviral overexpression to elucidate the roles of AKT/Protein kinase B isoforms in insulin actions. J Biol Chem, 2003, 278:28 312-23.

二级参考文献49

  • 1Sohail M, Doran G, Riedemann J, et al. A simple and cost-effective method for producing small interfering RNAs with high efficacy.Nucleic Acids Res, 2003,31 (7) : e38.
  • 2Kawasaki H, Taira K. Short hairpin type of dsRNAs that are controlled by tRNA(Val) promoter significantly induce RNAi-mediated gene silencing in the cytoplasm of human cells. Nucleic Acids Res,2003, 31 (2) :700-707.
  • 3Henmmings Mieszczak M, Dora G, Natt FJ, et al. Independent combinatorial effect of antisense oligonucleotides mad RNAi-mediated specific inhibition of the recombinant rat P2X3 receptor. Nucleic Acids Res,2003, 31(8) :2117 -2126.
  • 4Czaudema F, I%chtner M, Aygnn H. Functional studies of the PI(3)-kinase signalling pathway employing synthetic and expresseds iRNA. Nucleic Acids Res,2003, 31(2):670-682.
  • 5Zhang L, Yang N, Mohamed Hadley A, et al. Vector-based RNAia novel tool for isoform-specific knock-down of VEGF and anti-angiogenesis gene therapy of cancer. Biochem Biophys Reds Commun 2003,303(4) : 1169-1178.
  • 6Gschwind A, Hart S, Fischer OM, et al. TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells. EMBO J ,2003, 22(10) :2411-2421.
  • 7Nagy P, Amdt Jovin DJ, Jovin TM. Small interfering RNAs suppress the expression of endogenous and GFP-fused epidermal growth factor receptor (erbB1) and induce apoptosis in erbBl-overexpressing cells. Exp Cell Res, 2003,285 ( 1 ) : 39-49.
  • 8Riss D, Jin L, Qian X, et al. Differential expression of galectin-3 in pituitary tumors. Cancer Res, 2003, 63(9):2251-2255.
  • 9Gan L, Anton KE, Masterson BA. Specific interference with gene expression and gene function mediated by long dsRNA in neural cells. J Neurosci Methods, 2002, 121(2) : 151-157.
  • 10Nieth C, Priebsch A, Stege A, et al. Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference(RNAi). FEBS Lett, 2003, 545(2-3):144-150.

共引文献18

同被引文献12

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部